大眾公用(01635.HK)擬委任史平洋為非執行董事
格隆匯3月30日丨大眾公用(01635.HK)公吿,楊衞標先生因個人原因,辭任執行董事及公司副總裁職務;瞿佳女士因工作調整,由史平洋先生接替其擔任非執行董事及董事會戰略發展委員會委員職務;鄒小磊先生因其他工作安排,辭任獨立非執行董事及董事會審計委員會主席職務;及劉正東先生因其他工作需要,辭任獨立非執行董事及董事會審計委員會委員、董事會提名委員會主席及董事會薪酬與考核委員會委員職務。
董事會亦決議向股東周年大會尋求授權,授權其釐定下列委任的生效日期:委任史平洋先生為非執行董事;委任李穎琦女士為獨立非執行董事;委任楊平先生為獨立非執行董事;及委任劉峯先生為獨立非執行董事。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.